Brookemont Capital (TSX-V:BKT, StockForum), a Vancouver-based firm engaged in the exploration and evaluation of prospective mineral properties in Tanzania and Canada, announced today that the company's management would be actively pursuing additional growth drivers.
According to the news release, “The new areas that will be investigated will potentially include, but will not be limited to, agriculture, medical, pharmaceutical, resources and real estate. At this time no new project has been contemplated and there is no guarantee that one will be completed.”
Company president, Conrad Clemiss, commented, “We are constantly looking for projects that may increase shareholder value, and given the recent excitement generated within specific sectors such as medical marihuana, we would be not doing our job as if we did not look into a variety of projects that may help build BKT's assets.”
Brookemont Capital was in the news recently when the company encountered a large conductive anomaly on the Kenegami Hydrothermal Graphite Project.
Shares slipped 16.67% on the news to $0.025 per share.
Currently there are 83.2m outstanding shares with a market cap of $2.1 million.